“Having just made Daraprim much more costly, Turing was now offering to make it more affordable. But this is not a feel-good story. It’s a story about why expensive drugs keep getting more expensive, and how U.S. taxpayers support a billion-dollar system in which charitable giving is, in effect, a very profitable form of investing for drug companies — one that may also be tax-deductible.” It’s charity. But it’s profitable charity. From Bloomberg: How Big Pharma Uses Charity Programs to Cover for Drug Price Hikes.